Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves Perrigo’s generic Nicorette White Ice Mint Gum
These products will be packaged and marketed as store brands or retailer 'own label' brands and provide consumers with high-quality, value alternatives to Nicorette White Ice Mint Gum.
These products will be packaged and marketed as store brands or retailer 'own label' brands and provide consumers with high-quality, value alternatives to Nicorette White Ice Mint Gum.
The extension is the result of the submission of additional data by Genentech regarding the commercial manufacturing process of OCREVUS, which required additional time for FDA review. The
COMPASS is a randomized, double-blind, placebo-controlled, 26-week Phase 3 study evaluating volanesorsen in 113 patients with severe hypertriglyceridemia. The average incoming triglyceride level of patients in the study
Tresiba, first approved by the FDA in September 2015, is now indicated to improve glycemic control in patients with type 1 and type 2 diabetes from the age
Nimenrix is now the first and only MenACWY conjugate vaccine in the European Union (EU) that can be administered from six weeks of age with no upper age
Initial disease areas of focus will include Amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, and multiple other neurodegenerative disorders. Evotec has built an industrialised iPSC infrastructure that represents
The removal of the boxed warning is based on the outcomes of EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study), the largest smoking cessation clinical trial
This acquisition would add a once-daily oral H4 receptor antagonist in development for atopic dermatitis (AD), commonly known as eczema, to complement the growing Novartis dermatology portfolio and
Cancer Research UK’s Centre for Drug Development (CDD) will sponsor and fund a Phase Ia and Phase Ib clinical trial for a drug called BT1718, a Bicycle Drug
The deal covers the on-demand supply and distribution of BioQ Pharma’s pre-filled Ropivacaine Readyfusor for post-operative pain management in Europe, excluding France and Germany. Under the terms of